Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

CERULOPLASMIN - ANVISA Registration 10350840067

Access comprehensive regulatory information for CERULOPLASMIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10350840067 and manufactured by APTEC DIAGNOSTICS. The registration is held by BIOSYS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, SENTINEL CH. SPA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10350840067
Registration Details
ANVISA Registration Number: 10350840067
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

CERULOPAMIN AUT KIT (CERULOPLASMINA AUT KIT)
Risk Class II

Registration Details

10350840067

250000217569918

02220795000179

Company Information

APTEC DIAGNOSTICS
Belgium
PT: Bร‰LGICA

Dates and Status

Jan 10, 2000

VIGENTE

09/18/2025 19:00:01